the prefilled pen dials in 1-unit increments. The rapid-acting insulin should be administered subcutaneously within 5-10 minutes before a meal into the abdominal area, thigh, buttocks, or upper arm.

Merilog is a rapid-acting human insulin analog designed to reduce spikes ... This approval extends to a 3-milliliter single-patient-use prefilled pen and a 10-milliliter multiple-dose vial ...

NovoLog is also available in pen injector formats ... having a biosimilar option for their rapid-acting insulin injection can truly make a difference, as biosimilar products have the potential ...

Sanofi’s Admelog (insulin lispro) is approved in type 1 and type 2 diabetes as a follow-on drug to Humalog, a rapid-acting insulin ... form or as a disposable pen. Sanofi fights back This ...

The US Food and Drug Administration approved the first-ever rapid-acting insulin for reducing blood ... s 3-milliliter single-patient-use prefilled pen and a 10-milliliter multiple-dose vial.

NovoPen ®, the first insulin pen injector, was introduced in 1985. This article reviews the published evidence over two decades of use of the NovoPen ® family of injection devices in diabetes ...

Merilog is a rapid-acting human insulin analog and the first rapid-acting ... Both a 3-mL single-patient-use prefilled pen and a 10-mL multiple-dose vial are included in this approval.

As a rapid-acting insulin, Merilog helps to lower mealtime ... The approval is for both a 3 milliliter (mL) single-patient-use prefilled pen and a 10 milliliter (mL) multiple-dose vial.